Fatty liver disease in children: eat now pay later
- PMID: 20305757
- PMCID: PMC2836438
- DOI: 10.1007/s12072-009-9160-z
Fatty liver disease in children: eat now pay later
Abstract
Introduction: With the recent epidemic in childhood obesity, nonalcoholic fatty liver disease (NAFLD) has become an emerging problem and a common cause of chronic liver disease in children.
Methods: In this review, the most recent insights on the pathogenesis, diagnosis, natural history, and treatment of NAFLD in children are discussed.
Keywords: Children; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Obesity.
Figures
Similar articles
-
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).Adv Exp Med Biol. 2021;1261:223-229. doi: 10.1007/978-981-15-7360-6_20. Adv Exp Med Biol. 2021. PMID: 33783745
-
Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.BMC Pediatr. 2021 Mar 12;21(1):122. doi: 10.1186/s12887-021-02595-2. BMC Pediatr. 2021. PMID: 33711964 Free PMC article.
-
Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Gastroenterol Hepatol (N Y). 2006 Apr;2(4):282-291. Gastroenterol Hepatol (N Y). 2006. PMID: 28286458 Free PMC article.
-
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.J Clin Exp Hepatol. 2019 Jul-Aug;9(4):491-496. doi: 10.1016/j.jceh.2019.01.007. Epub 2019 Feb 7. J Clin Exp Hepatol. 2019. PMID: 31516265 Free PMC article. Review.
-
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777. World J Gastroenterol. 2015. PMID: 25852263 Free PMC article. Review.
Cited by
-
Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction.PLoS One. 2018 Jul 2;13(7):e0199916. doi: 10.1371/journal.pone.0199916. eCollection 2018. PLoS One. 2018. PMID: 29965973 Free PMC article.
-
Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway.Exp Biol Med (Maywood). 2015 Apr;240(4):508-18. doi: 10.1177/1535370214547123. Epub 2014 Aug 14. Exp Biol Med (Maywood). 2015. PMID: 25125496 Free PMC article.
-
Hepatic steatosis and Type 2 diabetes: current and future treatment considerations.Expert Rev Cardiovasc Ther. 2011 Mar;9(3):321-8. doi: 10.1586/erc.11.15. Expert Rev Cardiovasc Ther. 2011. PMID: 21438811 Free PMC article. Review.
-
Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.Nutrients. 2017 Sep 12;9(9):1006. doi: 10.3390/nu9091006. Nutrients. 2017. PMID: 28895929 Free PMC article.
-
Post-mortem MRI reveals CPT2 deficiency after sudden infant death.Eur J Pediatr. 2010 Dec;169(12):1561-3. doi: 10.1007/s00431-010-1261-0. Epub 2010 Jul 27. Eur J Pediatr. 2010. PMID: 20661589
References
LinkOut - more resources
Full Text Sources